---
$id: https://graph.org.ai/products/commodity/51141508
$type: Product
source: UNSPSC
code: "51141508"
title: "Ethosuximide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ethosuximide

**UNSPSC Code**: 51141508
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C7H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5SEH9X1D1D, chemically known as 2,5-pyrrolidinedione, 3-ethyl-3-methyl- but generally known as ethosuximide, which bears US NIH Compound Identifier 3291. European Medicines Agency schedules Ethosuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07282MIG. The term ETHOSUXIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules ethosuximide in its Anatomical Therapeutic Chemical (ATC) Classification. ETHOSUXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ethosuximide under HS 29251995 and SITC 51482. As of Q4 2014, ETHOSUXIMIDE remains the US FDA Preferred Term for this commodity. Ethosuximide bears US NLM identifiers UMLS ID C0015043 and NCI Concept Code C47523. SMILES: O=C1NC(=O)CC1(CC)C.

